Pan-RAS inhibitor daraxonrasib doubles survival in pancreatic cancer trial
A new review details how the pan-RAS inhibitor daraxonrasib doubled overall survival in a phase III pancreatic cancer trial and ...
Tag: KRAS mutations in cancer
MAPK Fuels Colorectal Cancer Therapy Resistance
In the relentless battle against colorectal cancer (CRC), a formidable challenge persists: the cancer’s uncanny ability to resist targeted therapies ...
Advancing Patient Outcomes in Pancreatic Cancer Care
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!